| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Surgical Oncology Research Laboratories, Massachusetts General Hospital; and Department of Surgery, Harvard Medical School, Boston, Massachusetts 02114
Elgadi, Khaled M., Robert A. Meguid, Ming Qian, Wiley W. Souba, and Steve F. Abcouwer. Cloning and analysis of unique human glutaminase isoforms generated by tissue-specific alternative splicing. Physiol. Genomics 1: 51–62, 1999.—Three human glutaminase (hGA) isoforms were identified, two of which represent isoforms previously unidentified in any species. One isoform contains an open reading frame with high homology with the rat kidney-type glutaminase, suggesting that this isoform represents the human kidney-type glutaminase, hKGA. A second isoform, termed hGAC, contains an open reading frame that matches hKGA except for a unique COOH-terminal amino acid sequence. In addition, a third human glutaminase isoform was identified from a computer search and on further analysis was found to represent an additional unique isoform, hGAM. hKGA is expressed predominantly in brain and kidney but not in liver, hGAC is expressed principally in cardiac muscle and pancreas but not in liver or brain, and hGAM is expressed solely in cardiac and skeletal muscle. hGAC is the predominant isoform expressed by a human breast cancer cell line that exhibits a high rate of glutamine utilization and glutaminase activity. Genomic Southern analysis as well as isolation and analysis of five glutaminase genomic clones suggested that all three hGA isoforms originate from the same locus and therefore represent mRNA species that are produced by tissue-specific alternative splicing of a single pre-mRNA. Furthermore, an RT-PCR assay was developed that can be used to easily differentiate between hKGA and hGAC mRNA species.
glutamine metabolism; mitochondrial proteins; gene expression; mRNA processing; CAG repeat polymorphisms; brain; kidney; muscle; mammary adenocarcinoma
This article has been cited by other articles:
|
|
 |
|
  J. P. Buschdorf, L. Li Chew, B. Zhang, Q. Cao, F.-Y. Liang, Y.-C. Liou, Y. T. Zhou, and B. C. Low Brain-specific BNIP-2-homology protein Caytaxin relocalises glutaminase to neurite terminals and reduces glutamate levels. J. Cell Sci., August 15, 2006; 119(Pt 16): 3337 - 3350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hara, K. Yamada, M. Terashima, H. Osago, M. Shimoyama, and M. Tsuchiya Molecular Identification of Human Glutamine- and Ammonia-dependent NAD Synthetases. CARBON-NITROGEN HYDROLASE DOMAIN CONFERS GLUTAMINE DEPENDENCY J. Biol. Chem., March 21, 2003; 278(13): 10914 - 10921. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. D. Porter, H. Ibrahim, L. Taylor, and N. P. Curthoys Complexity and species variation of the kidney-type glutaminase gene Physiol Genomics, June 3, 2002; 9(3): 157 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. P. Curthoys and G. Gstraunthaler Mechanism of increased renal gene expression during metabolic acidosis Am J Physiol Renal Physiol, September 1, 2001; 281(3): F381 - F390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. I. Labow, W. W. Souba, and S. F. Abcouwer Mechanisms Governing the Expression of the Enzymes of Glutamine Metabolism--Glutaminase and Glutamine Synthetase J. Nutr., September 1, 2001; 131(9): 2467S - 2474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Medina Glutamine and Cancer J. Nutr., September 1, 2001; 131(9): 2539S - 2542. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
